Facebook Linkedin RSS Twitter Youtube
Home 2024

Single cell sequencing

StockWatch: Analysts Positive on Illumina’s New Strategy
GEN Edge

StockWatch: Analysts Positive on Illumina’s New Strategy

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
GEN Edge

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares

StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x
GEN Edge

StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x

Aiming High: 10x, NanoString Launch Large-Scale Panels
GEN Edge

Aiming High: 10x, NanoString Launch Large-Scale Panels

Genetic Mosaicism Study Freshens Thinking about Old Blood
News

Genetic Mosaicism Study Freshens Thinking about Old Blood

CRISPR Screen Broadens and Quickens Study of Gene Function across Cell Types
Genome Editing

CRISPR Screen Broadens and Quickens Study of Gene Function across Cell Types

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard
GEN Edge

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard

Chronic Viral Infections Disrupt B Cells, Degrade Antibody Responses
Featured

Chronic Viral Infections Disrupt B Cells, Degrade Antibody Responses

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
GEN Edge

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?

10x Ships First Single Cell GEM-X Assays to Customers
GEN Edge

10x Ships First Single Cell GEM-X Assays to Customers

123...5Page 1 of 5
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.